Posts Tagged ‘vaccine0mg’

Covid Delta Variant Safety: Your Questions Answered – The New York Times

August 7, 2021

https://www.nytimes.com/2021/08/03/well/live/covid-delta-variant-vaccine-symptoms.html

jama_abbasi_2021_mn_210043_1627852635.57854.pdf

August 7, 2021

Medical News & Perspectives Quick Uptakes
July 14, 2021
Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination
Jennifer Abbasi
JAMA. 2021;326(5):376-377. doi:10.1001/jama.2021.11717

https://jamanetwork.com/journals/jama/fullarticle/2782139

Structure-based design of prefusion-stabilized SARS-CoV-2 spikes | Science

July 17, 2021

https://science.sciencemag.org/content/369/6510/1501

BY CHING-LIN HSIEH, JORY A. GOLDSMITH, JEFFREY M. SCHAUB, ANDREA M. DIVENERE, HUNG-CHE KUO, KAMYAB JAVANMARDI, KEVIN C. LE, DANIEL WRAPP, ALISON G. LEE, YUTONG LIU, CHIA-WEI CHOU, PATRICK O. BYRNE, CHRISTY K. HJORTH, NICOLE V. JOHNSON, JOHN LUDES-MEYERS, ANNALEE W. NGUYEN, JUYEON PARK, NIANSHUANG WANG, DZIFA AMENGOR, JASON J. LAVINDER, GREGORY C. IPPOLITO, JENNIFER A. MAYNARD, ILYA J. FINKELSTEIN, JASON S. MCLELLAN

SCIENCE18 SEP 2020 : 1501-1505

The design of stabilizing mutations in the SARS-CoV-2 spike protein allows for high-yield production of a critical vaccine antigen.

In particular,
stabilization is very important for the Moderna vaccine design.

This work builds on :
{{”
Science. 2013 Nov 1;342(6158):592-8. doi: 10.1126/science.1243283.

Structure-based design of a fusion glycoprotein vaccine for
respiratory syncytial virus

Jason S McLellan 1, Man Chen, M Gordon Joyce, Mallika Sastry, Guillaume B E Stewart-Jones, Yongping Yang, Baoshan Zhang, Lei Chen, Sanjay Srivatsan, Anqi Zheng, Tongqing Zhou, Kevin W Graepel, Azad Kumar, Syed Moin, Jeffrey C Boyington, Gwo-Yu Chuang, Cinque Soto, Ulrich Baxa, Arjen Q Bakker, Hergen Spits, Tim Beaumont, Zizheng Zheng, Ningshao Xia, Sung-Youl Ko, John-Paul Todd, Srinivas Rao, Barney S Graham, Peter D Kwong
Affiliations expand

PMID: 24179220 PMCID: PMC4461862 DOI: 10.1126/science.1243283 https://pubmed.ncbi.nlm.nih.gov/24179220/
“}}

The unseen covid-19 risk for unvaccinated people

July 17, 2021

This is the first newspaper article I’ve seen with a *methods* section at the end (which describes how #covid19 death rates could be “adjusted” for vaccine status)

https://www.washingtonpost.com/health/interactive/2021/covid-rates-unvaccinated-people

The unseen covid-19 risk for unvaccinated people

By Dan Keating and Leslie Shapiro

This story was published a few weeks ago but remains incredibly important as the delta variant spreads throughout the U.S.

The country’s declining covid-19 case rates present an unrealistically optimistic perspective for half of the nation — the half that is still not vaccinated.

As more people receive vaccines, covid-19 cases are occurring mostly in the increasingly narrow slice of the unprotected population. So The Washington Post adjusted its case, death and hospitalization rates to account for that — and found that in some places, the virus continues to rage among those who haven’t received a shot. Read more »

Pfizer and Moderna Vaccines Likely to Produce Lasting Immunity, Study Finds – The New York Times

July 1, 2021

https://www.nytimes.com/2021/06/28/health/coronavirus-vaccines-immunity.html

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose | Science

May 2, 2021

https://science.sciencemag.org/content/early/2021/04/29/science.abh1282

How to tweak the vaccines – ScienceDirect

April 3, 2021

https://www.sciencedirect.com/science/article/abs/pii/S026240792100172X

Vaccine manufacture – How vaccines are made, and why it is hard | Science & technology | The Economist

March 22, 2021

https://www.economist.com/science-and-technology/2021/02/06/how-vaccines-are-made-and-why-it-is-hard

Important Vaccine Eligibility Updates | COVID-19 Information

March 19, 2021

https://covid19.yale.edu/community-messages/important-vaccine-eligibility-updates

COVID Vaccine (COVID-19 Immunization Updates) | CVS Pharmacy

March 17, 2021

https://www.cvs.com/immunizations/covid-19-vaccine

CVS portal